Nalaganje...
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
BACKGROUND: Loss of the tumor suppressor phosphatase and tensin homolog (PTEN) occurs frequently in prostate cancers. Preclinical evidence suggests that activation of PI3K/AKT signaling through loss of PTEN can result in resistance to hormonal treatment in prostate cancer. OBJECTIVE: To explore the...
Shranjeno v:
| izdano v: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier Science
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4410287/ https://ncbi.nlm.nih.gov/pubmed/25454616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.10.027 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|